Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant. For the first...
A new study reports a genetically modified poliovirus therapy has been shown to improve long term survival rates in recurrent glioblastoma brain cancer patients. Researchers say the therapy had a three year survival rate for 21 percent of participants in a phase 1 clinical trial, compared to just 4% of patients who received more standard treatments.
Researchers at MIT have developed a new drug delivering nanoparticle that is able to cross the blood-brain barrier. The nanoparticles carry two different drugs that can help shrink tumors and prevent them from growing back.
A newly discovered weakness in brain tumor cells could provide a new target for treating glioblastoma, researchers report.
Researchers have successfully bypassed the blood-brain barrier using a laser probe to help deliver chemotherapy drugs to glioblastoma patients.
Researchers have identified an enzyme associated with aggressive gliomas.
Researchers suggest blocking DNA repair mechanisms could improve radiation therapy for glioblastoma brain cancer.
A new clinical trial will test whether an experimental vaccine can help patients' immune systems to stop the spread of deadly glioblastoma brain cancer.
According to a new study, computer modeling has been able to identify a molecule which inhibits a transient cellular event that drives glioblastoma brain cancer.
Researchers successfully grew adult human neurons from tissue donated from surgery patients. The researchers were able to identify at least 5 brain cell types and the potential proteins each cell could make.